PPOS vs GnRH Antagonist for IVF
IVF Outcomes With Time-Lapse Culture: Comparison Between PPOS and GnRH Antagonist Protocols
Recruiting
N/A
Interventional Study
Infertility (IVF Patients)
Embryo Morphokinetics
Progestins Primed Ovarian Stimulation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 20 – 45
- Sex
- Female
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 148 (estimated)
- Sponsor
- Hanoi Medical University · Other
Who this trial is looking for
This trial is looking for women aged 20-45 who need in vitro fertilization (IVF) treatment. Participants will use one of two protocols to stimulate their ovaries and undergo regular monitoring, with the option to freeze embryos for future use.
Are You a Good Fit for This Trial?
You may be able to join if
- I am between 20 and 45 years old.
- I need in vitro fertilization (IVF) treatment.
- I plan to freeze all my embryos.
- I agree to participate in research.
You may not be able to join if
- I have a systemic disease.
- I have used hormonal medications in the past 3 months.
- I am involved in an egg donation cycle.
- I am unwilling or unable to participate in research.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to compare two ovarian stimulation protocols used in in vitro fertilization (IVF): the fixed Progestin-Primed Ovarian Stimulation (PPOS) protocol and the GnRH Antagonist protocol. The study will evaluate IVF outcomes and embryo development patterns using time-lapse embryo monitoring technology. The main questions the study aims to answer are:
* Does the fixed - …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Women aged 20-45 years
* Indicated for in vitro fertilization (IVF) treatment
* Planned freeze-all embryo strategy
* Voluntary participation in research.
Exclusion Criteria:
* Systemic diseases
* Use of hormonal medications within 3 months prior to enrollment
* Oocyte donati…
Contacts